Understanding the host-pathogen interaction saves lives: Lessons from vaccines and vaccinations

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 8-13

  Garon, Julie R ^a   Orenstein, Walter A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA TETANUS TOXOID; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED POLIO VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG; VACCINE;

ACUTE BRAIN DISEASE; ADVISORY COMMITTEE; BRAIN DAMAGE; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; DRUG DOSE REGIMEN; DRUG MONITORING; DRUG SAFETY; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; FAILURE TO VACCINATE; FEVER; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFLUENZA VIRUS; INTUSSUSCEPTION; LICENSING; NONHUMAN; PROPHYLAXIS; REVIEW; ROTAVIRUS; UNITED STATES; VACCINATION; VACCINATION REACTION; VACCINE FAILURE; VACCINE PRODUCTION; ADVERSE EFFECTS; ANIMAL; COMMUNICABLE DISEASE CONTROL; ECONOMICS; IMMUNOLOGY; LEGISLATION AND JURISPRUDENCE; PROCEDURES;

ANIMALS; COMMUNICABLE DISEASE CONTROL; HOST-PATHOGEN INTERACTIONS; HUMANS; VACCINATION; VACCINES;

EID: 84929085187     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.04.003     Document Type: Review

References (33)

1. Ranking Vaccines: A Prioritization Software Tool: Phase II: Prototype of a Decision-support System 2015, Available from: http://books.nap.edu/openbook.php?record_id=13531 [cited 07.04.15].
2. Bandyopadhyay A.S., Garon J., Seib K., Orenstein W.A. Polio vaccination: past, present and future. Fut Microbiol 2015, 31:1-18.
3. Guidance for Health Economics Studies Presented to the ACIP 2015, Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, Available from: http://www.cdc.gov/vaccines/acip/committee/guidance/economic-studies.html [cited 08.04.15].
4. LeBaron C.W., Beeler J., Sullivan B.J., Forghani B., Bi D., Beck C., et al. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med 2007, 161:294-301.
5. Strebel P., Papania M., Fiebelkorn A.P., Halsey N. Chapter 20: Measles Vaccine Vaccines 2015, 352-387. Elsevier/Saunders, Available from: https://expertconsult.inkling.com/read/vaccines-plotkin-orenstein-offit-6th/chapter-20/measles-vaccine [cited 26.03.15]. 6th ed.
6. Gerhard W., Mozdzanowska K., Zharikova D. Prospects for universal influenza virus vaccine. Emerg Infect Dis 2006, 12:569-574.
7. Krammer F., Palese P. Universal influenza virus vaccines: need for clinical trials. Nat Immunol 2014, 15:3-5.
8. Liu J., Tran V., Leung A.S., Alexander D.C., Zhu B., Vaccines: B.C.G. Their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin 2009, 5:70-78.
9. Delany I., Rappuoli R., De Gregorio E. Vaccines for the 21st century. EMBO Mol Med 2014, 6:708-720.
10. Klugman K., Black S., Dagan R., Malley R., Whitney C. Chapter 25: pneumococcal conjugate vaccine and pneumococcal common protein vaccines. Vaccines 2015, 504-541. Available from: https://expertconsult.inkling.com/read/vaccines-plotkin-orenstein-offit-6th/chapter-25/introduction [cited 01.04.15]. edn 6.
11. Davis S.M., Deloria-Knoll M., Kassa H.T., O'Brien K.L. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 2013, 32:133-145.
12. Sutter R.W., Kew O.M., Cochi S.L., Aylward R.B. 28-poliovirus vaccine-live. Vaccines 2013, 598-645. W.B. Saunders, London, Available from: http://www.sciencedirect.com/science/article/pii/B9781455700905000355. edn 6. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
13. Vidor E. Chapter 27: poliovirus vaccine-inactivated. Vaccines 2013, 573-597. Elsevier/Saunders, Philadelphia. edn 6.
14. Global Polio Eradication Initiative Polio Eradication & Endgame Strategic Plan 2013-2018 2013, Available from: http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/PEESP_EN_US.pdf.
15. Wharton M. Vaccine safety: current systems and recent findings. Curr Opin Pediatr 2010, 22:88-93.
16. Kapikian A.Z., Flores J., Hoshino Y., Glass R.I., Midthun K., Gorziglia M., et al. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. J Infect Dis 1986, 153:815-822.
17. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control 1999, 48:1-20.
18. Clemens J., Keckich N., Naficy A., Glass R., Rao M. Public health considerations for the introduction of new rotavirus vaccines for infants: a case study of tetravalent rhesus rotavirus-based reassortant vaccine. Epidemiol Rev 1999, 21:24-42.
19. Rennels M.B., Parashar U.D., Holman R.C., Le C.T., Chang H.G., Glass R.I. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr Infect Dis J 1998, 17:924-925.
20. Zanardi L.R., Haber P., Mootrey G.T., Niu M.T., Wharton M. Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system. Pediatrics 2001, 107. e97.
21. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001, 344:564-572.
22. Centers for Disease Control and Prevention (CDC) Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999, 48:1007.
23. Stockwell M.S., Broder K., LaRussa P., Lewis P., Fernandez N., Sharma D., et al. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine. JAMA Pediatr 2014, 168:211-219.
24. National Vaccine Injury Compensation Program 2015, Available from: http://www.hrsa.gov/vaccinecompensation/index.html [cited 30.03.15].
25. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Centers Dis Control 2008, 57:1-60.
26. Prevention and Control of Influenza with Vaccines 2015, Centers for Disease Control and Prevention, Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5908a1.htm [cited 01.04.15].
27. Clements K.M., Chancellor J., Nichol K., DeLong K., Thompson D. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States. Value Health J Int Soc Pharmacoecon Outcomes Res 2011, 14:800-811.
28. Jordan R., Connock M., Albon E., Fry-Smith A., Olowokure B., Hawker J., et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 2006, 24:1047-1062.
29. Weycker D., Edelsberg J., Halloran M.E., Longini I.M., Nizam A., Ciuryla V., et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005, 23:1284-1293.
30. Orenstein W.A., Papania M.J., Wharton M.E. Measles elimination in the United States. J Infect Dis 2004, 189(Suppl. 1):S1-S3.
31. Public Sector Response to the Resurgence of Measles Among Preschool-aged Children-United States 1989-1991. Report No.: 41 1992, 522-525. Centers for Disease Control and Prevention, Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/00017268.htm [cited 09.04.15].
32. Lavail K.H., Kennedy A.M. The role of attitudes about vaccine safety, efficacy, and value in explaining parents' reported vaccination behavior. Health Educ Behav Off Publ Soc Public Health Educ 2013, 40:544-551.
33. Wallace A.S., Mantel C., Mayers G., Mansoor O., Gindler J.S., Hyde T.B. Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: lessons for vaccine introduction. Vaccine 2014, 32:5301-5310.